Take drug management to the next level with pharmacogenomics
The PGxOne™ Plus test was designed to assist in selecting a patient’s medications for multiple therapeutic areas with easy implementation in mind. Adhering to the highest levels of clinical evidence, test results may help with:
- Improving patient outcomes
- Reducing adverse drug events
- Avoiding trial and error prescribing
- Improving patient compliance
- Increasing practice efficiencies and lowering costs
Take drug management to the next level with pharmacogenomics
The PGxOne™ Plus test was designed to assist in selecting a patient’s medications for multiple therapeutic areas with easy implementation in mind. Adhering to the highest levels of clinical evidence, test results may help with:
- Improving patient outcomes
- Reducing adverse drug events
- Avoiding trial and error prescribing
- Improving patient compliance
- Increasing practice efficiencies and lowering costs
Take drug management
to the next level with
pharmacogenomics
The PGxOne™ Plus test was
designed to assist in
selecting a patient’s
medications for multiple
therapeutic areas with
easy implementation in mind.
Adhering to the highest levels
of clinical evidence, test
results may help with:
- Improving patient outcomes
- Reducing adverse drug events
- Avoiding trial and error prescribing
- Improving patient compliance
- Increasing practice efficiencies and lowering costs
Drug response can be impacted by multiple factors, including pharmacodynamics and pharmacokinetics
The PGxOne™ Plus report provides biological systems-based recommendations with test results accounting for medications being influenced by multiple genetic variants, first individually and then in one combined patient impact statement.
Biological Systems Based results across multiple therapeutic areas are organized with rapid implementation in mind
Test results include specific sections for Current Medications and Medications of Interests followed by a comprehensive sections. Results are organized alphabetically by therapeutic area, drug class, and mechanism of action.
The PGxOne™ Plus test combines with RxVision™, a dynamic online reporting tool, to provide a complete PGx assessment
High-integrity gene-drug interactions align with sources from the FDA with additional PGx information available in RxVision that is sourced from the FDA, Clinical Pharmacogenetics Implementation Consortium (CPIC), Association for Molecular Pathologists (AMP), and the College of American Pathologist (CAP).
PGx Providers’ Benefits
.
908-222-0533 EXT 3342).Getting Started
. Implementing PGx into your Practice is an Easy Process
- Identify a reason for testing
a patient - Patient consents to testing after being informed of its ethical, legal, and social risks as well as benefits/limitations
- Admera Health preforms the testing and billing
- Provider receives PGx results and processes/documents them into the patient’s medical record
- Provider integrates PGx test results into medication management decisions and counsels the patient
- Clinical supportive services are available Monday through Friday 8 am to 6 pm EST by calling 844-4ADMERA (844.423.6372), or by scheduling
a call.
- Clinical supportive services are available Monday through Friday 8 am to 6 pm EST by calling
- Establish mechanism of reporting results to patients and addressing unexpected findings (if any)
